Prostate Cancer Market

The research report offered by MarkNtel Advisors brings detail-driven, unbiased, and accurate research on the Prostate Cancer Market, covering aspects associated with the changing interface of the market over the years. The analysis covers data from the historic years 2017-20 and the base year 2021, put together in a way to bring out estimations for the forecast period 2022-27.

This study is relentless & integrates an extensive & detail-driven examination of the industry, portraying elements like drivers, restraints, opportunities, challenges, key trends, & recent developments, among others. These parameters are associated with their influence on the market growth, preparing the stakeholders to get an idea of what to expect in the future.

In June 2021, Novartis International AG announced receiving approval from the US Food & Drug Administration (FDA) for the Breakthrough Therapy Designation (BTD) to 177Lu-PSMA-617 in patients with conditions of metastatic castration-resistant prostate cancer (mCRPC).

Request Sample Report of Prostate Cancer Market: - https://www.marknteladvisors.com/query/request-sample/prostate-cancer-market.html

Segmentation Analysis

This section reveals the key parameters influencing the market expansion in diverse segments across locations. The researchers bring together an analysis covering aspects like the overall size & volume of products/services, their demands, and the fluctuations in the industry. In addition, this section also incorporates information allowing the stakeholders to procure knowledge on the demand, sales, production, & distribution mapping & their potential growth in the coming years.

Based on, By Diagnosis

- Tissue Biopsy

- Transrectal Ultrasound

- Prostate-specific Antigen Testing

- Urine Testing

- Imaging

Based on, By Treatment

- Surgery

-- Radical Prostatectomy

-- Cryotherapy

-- Orchiectomy (Surgical Castration)

- Hormone Therapy

-- LHRH (Luteinizing Hormone-Releasing Hormone) Agonists

--- Leuprolide (Lupron, Eligard)

--- Goserelin (Zoladex)

--- Triptorelin (Trelstar)

--- Leuprolide mesylate (Camcevi)

-- LHRH (Luteinizing Hormone-Releasing Hormone) Antagonists

--- Degarelix (Firmagon)

--- Relugolix (Orgovyx)

- Radiation Therapy

-- External Beam Radiation Therapy (EBRT)

--- Proton Beam Radiation Therapy

--- Three-Dimensional Conformal Radiation Therapy (3D-CRT)

--- Stereotactic Body Radiation Therapy (SBRT)

-- Brachytherapy (Internal Radiation Therapy)

-- Radiopharmaceuticals

- Chemotherapy

-- Docetaxel (Taxotere)

-- Cabazitaxel (Jevtana)

-- Mitoxantrone (Novantrone)

-- Estramustine (Emcyt)

- Targeted Therapy

-- Rucaparib (Rubraca)

-- Olaparib (Lynparza)

Based on, By End-User

- Hospitals

- Clinics

Read Full Report Description with Table of Content and Figure: - https://www.marknteladvisors.com/research-library/prostate-cancer-market.html

Geographically, the Prostate Cancer Market scales across the following regions/countries:

- North America

- South America

- Europe

- The Middle East & Africa

- Asia Pacific

Competitive Analysis

With exhaustive research & complete company profiling by the researchers, the competitive landscape in the Prostate Cancer Market report is a compilation of the changing interface, sustainability tactics, and strategies adopted by the prominent players for sustainability & higher yields in the industry. These aspects are grounded on the following parameters:

- Investments & Developments

- Overview of the company & business strategy

- Product/Service portfolio expansion

- The geographical presence of players

- Trends & recent developments

- Performance indicators

The prominent companies profiled in the Prostate Cancer Market report are listed below:

- Abbott Laboratories

- AbbVie Inc.

- Amgen Inc.

- AstraZeneca PLC

- Bayer AG

- Bristol Myers Squibb

- Eisai Co. Ltd.

- Eli Lilly and Company

- F. Hoffmann-La Roche AG

- GlaxoSmithKline PLC

- Merck & Co., Inc.

- Novartis International AG

- Pfizer Inc.

- Sanofi S.A.

- Others

Speak to the Analyst for more details: - https://www.marknteladvisors.com/query/talk-to-our-consultant/prostate-cancer-market.html

Top Reasons to Invest in the Prostate Cancer Market Report

• The Prostate Cancer Market research report furnishes unbiased & accurate perspicuity into the changing interface of the industry. It solely aims to help the stakeholders to develop business strategies after understanding the key trends influencing the market.

• This analysis talks about the potential market growth in the future & the competitive scenario for strategic investments. Here, the stakeholders are enlightened with greater efficiency in organizing the sales & marketing efforts by closely studying the opportunities presented in the research.

• Using this compilation of accurate analysis of the competitive landscape in the study, the stakeholders can also identify a strong upcoming competition & devise their strategies to get ahead of the competitors in the future.

Read our latest Press Release on the Prostate Cancer Market: https://www.marknteladvisors.com/press-release/prostate-cancer-market-growth

*Visit the official website of the MarkNtel Advisors to avail of customization services & detailed insights on the different industries at affordable prices.

For Any Query Contact at- sales@marknteladvisors.com

Call at- +1 604 800 2671, +91 120 4311129

Read our Latest Blog

Surface Treatment Chemicals: Different Types & Methods, Key Applications: https://www.marknteladvisors.com/blogs/surface-treatment-chemicals-types-and-method.html

Men's Grooming Products: Breaking Stereotypes in India: https://newscluster24.com/mens-grooming-products-breaking-stereotypes-in-india/

Understanding the Concepts of Data Monetization in the Automotive Sector: https://www.marknteladvisors.com/blogs/understanding-concepts-of-data-monetization-automotive-sector.html

How is Rapid Climate Change impacting the Residential Boiler Production?: https://newscube24.com/how-is-rapid-climate-change-impacting-the-residential-boiler-production/